Iovance Biotherapeutics Stock Market Value
| IOVA Stock | USD 9.40 0.28 3.07% |
| Symbol | Iovance |
Iovance Biotherapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iovance Biotherapeutics. If investors know Iovance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iovance Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.48) | Revenue Per Share 0.327 | Quarterly Revenue Growth 123.851 | Return On Assets (0.29) | Return On Equity (0.57) |
The market value of Iovance Biotherapeutics is measured differently than its book value, which is the value of Iovance that is recorded on the company's balance sheet. Investors also form their own opinion of Iovance Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Iovance Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iovance Biotherapeutics' market value can be influenced by many factors that don't directly affect Iovance Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iovance Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Iovance Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iovance Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Iovance Biotherapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Iovance Biotherapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Iovance Biotherapeutics.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in Iovance Biotherapeutics on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Iovance Biotherapeutics or generate 0.0% return on investment in Iovance Biotherapeutics over 30 days. Iovance Biotherapeutics is related to or competes with PTC Therapeutics, Krystal Biotech, Sarepta Therapeutics, Madrigal Pharmaceuticals, CureVac NV, Apellis Pharmaceuticals, and Ocean Biomedical. Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer ... More
Iovance Biotherapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Iovance Biotherapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Iovance Biotherapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 23.06 | |||
| Value At Risk | (6.95) | |||
| Potential Upside | 7.54 |
Iovance Biotherapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Iovance Biotherapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Iovance Biotherapeutics' standard deviation. In reality, there are many statistical measures that can use Iovance Biotherapeutics historical prices to predict the future Iovance Biotherapeutics' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.47) | |||
| Total Risk Alpha | (0.86) | |||
| Treynor Ratio | (0.09) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Iovance Biotherapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Iovance Biotherapeutics Backtested Returns
Iovance Biotherapeutics holds Efficiency (Sharpe) Ratio of -0.0545, which attests that the entity had a -0.0545% return per unit of risk over the last 3 months. Iovance Biotherapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Iovance Biotherapeutics' Risk Adjusted Performance of (0.03), standard deviation of 4.35, and Market Risk Adjusted Performance of (0.08) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 2.25, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Iovance Biotherapeutics will likely underperform. At this point, Iovance Biotherapeutics has a negative expected return of -0.24%. Please make sure to check out Iovance Biotherapeutics' kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if Iovance Biotherapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.74 |
Almost perfect reverse predictability
Iovance Biotherapeutics has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Iovance Biotherapeutics time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Iovance Biotherapeutics price movement. The serial correlation of -0.74 indicates that around 74.0% of current Iovance Biotherapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.74 | |
| Spearman Rank Test | 0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.23 |
Iovance Biotherapeutics lagged returns against current returns
Autocorrelation, which is Iovance Biotherapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Iovance Biotherapeutics' stock expected returns. We can calculate the autocorrelation of Iovance Biotherapeutics returns to help us make a trade decision. For example, suppose you find that Iovance Biotherapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Iovance Biotherapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Iovance Biotherapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Iovance Biotherapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Iovance Biotherapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Iovance Biotherapeutics Lagged Returns
When evaluating Iovance Biotherapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Iovance Biotherapeutics stock have on its future price. Iovance Biotherapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Iovance Biotherapeutics autocorrelation shows the relationship between Iovance Biotherapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Iovance Biotherapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Iovance Biotherapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Iovance Biotherapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Iovance Biotherapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Iovance Biotherapeutics Stock:Check out Iovance Biotherapeutics Correlation, Iovance Biotherapeutics Volatility and Iovance Biotherapeutics Alpha and Beta module to complement your research on Iovance Biotherapeutics. For information on how to trade Iovance Stock refer to our How to Trade Iovance Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Iovance Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.